SlideShare a Scribd company logo
CORONARY ARTERIES
Distribution of coronary blood
supply
Right Coronary Artery Left Coronary Artery
Right atrium
Right ventricle
SA node (85%)
AV node
Inter-atrial septum
Portion of left atrium
Postero-inferior 1/3 of Inter-
ventricular septum
Portion of posterior part of left
ventricle
Left atrium
Left ventricle
Most of the Interventricular
septum
Atrio-ventricular bundle and its
branches
ACUTE MYOCARDIAL INFARCTION
• Cardiac muscle
necrosis secondary
to protracted lack
of coronary
perfusion
• Usual etiology:
Thrombus at site of
vascular injury
OTHER ETIOLOGIES OF ACUTE
MYOCARDIAL INFARCTION
• Coronary embolus
• Coronary spasm
• Coronary anomoly
• Primary in situ thrombosis
• Vasculitis
• Hypotension
DETERMINANTS OF EXTENT OF DAMAGE
• Territory supplied
• Duration of occlusion
• Existence of collaterals
• Oxygen demand at time of occlusion
• Vasospasm
RISK FACTORS
Risk factors for atherosclerosis are generally risk factors for
myocardial infarction
Diabetes (with or without insulin resistance) – the single
most important risk factor for ischaemic heart disease (IHD)
Tobacco smoking
Hypercholesterolemia
Low HDL
High blood pressure
Family history of ischaemic heart disease (IHD)
Obesity
Age: Men at age 45 & Women at age 55
Hyperhomocysteinemia (high homocysteine, a toxic
blood amino acid that is elevated when intakes of
vitamins B2, B6, B12 and folic acid are insufficient)
Stress
Alcohol
Males are more at risk than females
Presenting Symptoms of Acute MI
• Pain-
*typical-crushing substernal chest pain
*atypical - jaw, neck, shoulder, back pain, indigestion
*painless - “silent”
• Dyspnea-
systolic and/or diastolic dysfunction
• Dizziness-hypotension, arrhythmia
• Nausea, vomiting
• Elderly patients: Failure to thrive
• Anxiety, restlessness
CHEST PAIN
Presenting Signs in Acute MI
• Appearance: Pallor, diaphoretic, anxious
• Vital Signs: Normal or abnormal BP and P
– Hypertension and tachycardia: SNS
– Hypotension and tachycardia:
• Cardiogenic shock
• Myocardial rupture
• Tachyarrhythmia
– Hypotension and bradycardia
• vagal stimulation
• Bradyarhythmia
Presenting Signs in Acute MI (Cont.)
• Lungs: Rales - CHF
• Heart: Displaced LV impulse
–S3
–S4
–Murmur of mitral regurgitation
–Murmur of ventricular septal
rupture
–Pericardial rub
DIAGNOSIS
The diagnosis of myocardial infarction can be
made after assessing
Patient's complaints and physical status
ECG changes
Coronary angiogram
Levels of cardiac markers
ORDER OF ECG CHANGES IN AMI
 Earliest: Increased R and T wave amplitudes; giant R wave and
Hyperacute T waves
 Progressive ST elevation
 Q waves appear
 Loss of R waves
 “T wave” inversion (because of change in ventricular repolarisation)
and it persists
HYPERACUTE “T WAVES”
Electrocardiographic Differential Diagnosis
of the Hyperacute T Wave
A: AMI
B: AMI
C: Hyperkalemia
D: Benign Early Repolarization
E: Acute Pericarditis
F: LBBB
G: LVH
T Wave Inversion in ACS
INFARCTION DISTRIBUTION
TERRITORY ECG LEADS ARTERY
Anterior V2-V6 LAD
Inferior II,III, aVF RCA
Lateral I, aVL, V5-V6 Circumflex
Posterior Tall R in V1-V2 Variable
ANTERIOR AMI
STE in V1-V4
ANTEROLATERAL AMI
STE in V2-V4 Anterior
STE in I, aVL, V5-V6 Lateral
LATERAL AMI
STE in I, aVL
*Note the ST depression in II, III, aVF consistent
with reciprocal changes, as well as in V2-V3 which
may represent a posterior MI
INFERIOR AMI
STE in II, III, aVF
*Note the ST depression in I, aVL consistent with
reciprocal change, as well as in V1-V4 representing a
posterior MI
POSTERIOR WALL AMI
ST Segment Depression in V1-V3 and posterior thoracic
leads with STE
PLASMA MARKERS
CK-MB
Increases at 4-6 hours
Peaks at 12 hours
Normalizes in 48-72 hours
TROPONIN T & I
Increases at 4-6 hours
Remains elevated for 2
weeks
Creatine Phosphokinase (CK)
• Rises within 4-8 hours, rapidly cleared by 24-24 hours
• Other Sources:
– Skeletal
– Hypothyroidism
– Renal failure
– Stroke
• Isoenzymes
– MM skeletal muscle
– BB brain
– MB cardiac
• CKMB≥ 4% suggests acute myocardial infarction+++
Cardiac Specific Troponins (cTnT, cTnI)
• Rise within 4-8 hours, remain elevated 7-14
days (T>I)
• 30% of patients with UAP show ↑ levels cTnT
or I, indicating increased risk of adverse
outcome
OTHER TESTS
BLOOD leukocytosis, ESR and CRP is elevated
Chest X-ray Pulmonary edema
Echocardiography
Mural thrombi
Cardiac rupture
VSD
MR
Pericardial effusion
DIAGNOSIS OF MYOCARDIAL
INFARCTION (American college of cardiology
and the Europeon society of cardiology)
Elevated Troponins or CK-MB above 99th
centile with
one of the following
Ischemic symptoms
Development of Q-waves on ECG
Ischemic ECG changes (ST elevation/depression)
Coronary artery intervention
A. IMMEDIATE
MANAGEMENT
B. MAINTAINING
VESSEL PATENCY
C. PREVENTION
OF FURTHER
COMPLICATIONS
D. LATE
MANAGEMENT
Defibrillation
services
Resuscitation
Reperfusion
Detection and
Management of
acute
complications
Drugs
Adjunctive
therapy
Arrythmias
Ischemia
Acute circulatory
failure
Pericarditis
Mechanical
complications
Embolism
Impaired
ventricular function
Ventricular
aneurysm
Risk stratification
and management
Life style
modification
Drug therapy in
Secondary
Prevention
Mobilization and
Rehabilitation
A. IMMEDIATE MANAGEMENT
DEFIBRILLATOR
IMMEDIATE MEASURES
1.High flow oxygen
2.IV access
3.ECG monitoring
4.IV analgesics (Morphine Sulphate 5-10 mg)
5.Anti-emetics (Metoclopramide 100mg)
6.Anti-platelets (Aspirin 300mg)
REPERFUSION
 Primary PCI is the treatment of choice
 Thrombolysis (Greatest benefits if in 2 hours)
Streptokinase 1.5 Million Units in 100ml of N/S over 1 hour
Alteplase 15mg bolus then 0.75mg/kg in 30 mins (50mg)
followed by 0.5mg/kg in 60 min (35mg)
Major hazard is Cerebral Haemorrhage
DETECTION AND MANAGEMENT OF ACUTE
COMPLICATIONS
 Arrythmias
 Ischemia
 Heart failure
Major Contraindications To the Use of
Thrombolytic Therapy
• Any previous history of hemorrhagic stroke
• History of stroke, dementia, or central nervous system
damage within 1 year
• Head trauma or brain surgery within 6 months
• Known intracranial neoplasm
• Suspected aortic dissection
• Internal bleeding within 6 weeks
• Active bleeding or known bleeding disorder
• Major surgery, trauma, or bleeding within 6 weeks
• Traumatic cardiopulmonary resuscitation within 3 weeks
Relative Contraindications To the Use of
Thrombolytic Therapy
• Oral anticoagulant therapy
• Acute pancreatitis
• Pregnancy or within 1 week postpartum
• Active peptic ulceration
• Transient ischemic attack within 6 months
• Dementia
• Infective endocarditis
• Active cavitating pulmonary tuberculosis
• Advanced liver disease
• Intracardiac thrombi
• Uncontrolled hypertension (systolic blood Pressure >180 mm Hg, diastolic blood pressure >
110 mm Hg
• Puncture of noncompressible blood vessel within 2 weeks
• Previous streptokinase therapy
Risks of Coronary Angiography: (all
are rare)
• Stroke
• Myocardial infarction
• Arrhythmia
• Renal failure
• Allergic reaction to contrast agent
B. MAINTAINING VESSEL PATENCY
• Anti-platelets
Aspirin 75-300mg daily and/or Clopidogrel 75mg daily
• Anti-coagulants
S/C Heparin 12,500 units twice daily
IV Heparin (within 48-72 hrs of thrombolysis)
Warfarin in Persistant A.Fibrillation & Extensive anterior
infarction
• Adjunctive therapy
B-Blockers Atenolol 5-10mg to dec. pain and arrythmias but
should be avoided in HF, AV Block and severe bradycardia
Nitrates S/L GTN 300-500 mcg in threatened MI and IV nitrates
(Nitroglycerin 0.6-1.2mg/hour or Isosorbide dinitrate are
useful in treating LVF and Ischemic pain relief.
C. FURTHER COMPLICATIONS AND THEIR
PREVENTION
1. ARRYTHMIAS (VF, VT, AF, AT, Heart blocks and
Ventricular ectopics)
Can be avoided by Pain relief, Rest and Correction of
hypokalemia
• Vent. Fib….5-10% cases…..prompt defibrillation
• Atrial Fib….transient and rarely requires treatment
….DC cardioversion, Digoxin or B-Blocker are
TOCs…..Patient can go into LVF so give
Anticoagulants
• AV block….Atropine 0.6mg IV + Temporary
pacemaker
2. ISCHEMIA 50% cases known as post-infarct Angina
Managed as Unstable Angina
• IV nitrates (0.6-1.2mg/hour)
• IV heparin (1000 units/hour)…dose adjusted to PT
• LMWH
• GP IIb/IIIa receptor antagonists…..selected cases
3. ACUTE CIRCULATORY FAILURE in extensive myocardial
damage
4. PERICARDITIS (on 2nd
and 3rd
day)
Opiod based analgesics
Also called Post-Infarction syndrome/Dressler’s
syndrome…..fever, pericarditis and pleurisy (due to
auto-immunity)….may require High dose Aspirin,
other NSAIDS and Cortico-steriods.
5. MECHANICAL COMPLICATIONS
Papillary muscle damage…..acute onset pulmonary
edema due to severe MR (PSM + S3)…..diagnosed by
doppler’s echocardiography and treated by
emergency mitral valve replacement
Ruptured IV septum…..Left to right shunt (PSM
radiating to right sternal border difficult to
distinguish from MR) …..diagnosed on doppler’s
echocardiography …..fatal condition
Ventricular rupture…..cardiac tamponade…..fatal
6. EMBOLISM risk is decreased by prophylactic ani-
coagulants and early mobilization
7.IMPAIRED VENTRICULAR FUNCTION
Due to infarct expansion…..lead to progressive
dilataion of the infarcted area and hypertrophy of
the rest of the portion
8. VENTRICULAR ANEURYSM 10% cases
Leads to HF, Ventricular arrythmias, Mural thrombus
and systemic embolism
Echocardiography is diagnostic
Surgical removal improves the chances of survival
D. LATE MANAGEMENT
1. RISK STRATIFICATION
LV FUNCTION ISCHEMIA ARRYTHMIAS
•Physical findings …
tachycardia, S3,
Crackles at lung
bases and elevated
venous pressure
•ECG changes
•Size of heart and
Pulmonary edema
on CXR
•Post-infarct angina …
treat like unstable angina
•CABG
•Implantable cardiac
defibrillators
2. LIFE STYLE MODIFICATION
 Quit smoking (5 year mortality twice if you don’t
quit)
 Regular exercise (20min/day for 3 days/week)
 Diet control to decrease weight and lipid lowering
3. DRUG THERAPY (Secondary prevention)
Statins…best results when level of LDL is greater than 3.2
mmol/L….Atovstatin 80mg OD
Anti-platelets…Aspirin/Clopidogrel
B-Blockers….but contra-indicated in Bradycardia, AV block,
hypotension and Asthma
ACE inhibitors….Enalapril 10mg BD, Ramipril 2.5-5mg BD
Angiotensin receptor antagonists….valsartan 40-160mg OD,
Candesartan 4-16mg OD
Control of HTN and DM
4. MOBILIZATION AND REHABILITATION start working in 4-6
weeks
CARDIAC REHABILITATION
•Healthcare professionals,
should actively promote
cardiac rehabilitation.
•Cardiac rehabilitation
should be equally accessible
and relevant to all patients
after an acute MI.
COMPONENTS OF CARDIAC
REHABILITATION
• The guideline recommends that cardiac
rehabilitation should include:
• education
• exercise
• stress management
CARDIOLOGICAL ASSESSMENT
All patients should be
offered a cardiological
assessment to consider
whether coronary
revascularisation is
appropriate.
ABCs of Treatment and Secondary
Prevention of AMI
• Aspirin-prophylactic Rx for recurrent ischemic events;
give for at least 3 mo. after AMI, probably indefinitely
• Beta blockers-prophylactic, for reduction of cardiac
mortality; Rx for 2 yr-indefinitely
• Converting enzyme inhibitors-all pts with LV
dysfunction to reduce risk of progressive heart failure
and death.
• Diet and lipid lowering Rx-statins have been shown to
reduce risk of subsequent MI, need for
revascularization and mortality (4S, Care)
• Exercise and rehabilitation-essential in restoration of
confidence and improvement in quality of life
PROGNOSIS
• 1/4th
of the patients suffering acute MI die in few
min due to any arrythmia
• Half of the MI deaths occur in 1st
24 hours
• 40% of the rest die in 1st
Month
• Anterior infarcts are worse than Inferior infarcts
• BBB and increased enzymes reflects that the
damage is extensive
• Increased mortality is associated with old
age,depression and social isolation
SURVIVAL CHANCES
After surviving an acute attack….
• 80 % Survive the 1st
year
• 75 % Survive upto 5 years
• 50% Survive upto 10 years
• 25% survive upto 20 years
Acute myocardial infarction

More Related Content

What's hot

Acute Coronary Syndrome
Acute Coronary SyndromeAcute Coronary Syndrome
Acute Coronary Syndrome
www.slideworld.org
 
Myocardialinfarction
Myocardialinfarction Myocardialinfarction
Myocardialinfarction
s o a university
 
ACUTE CORONARY SYNDROME
ACUTE CORONARY SYNDROMEACUTE CORONARY SYNDROME
ACUTE CORONARY SYNDROME
KELVIN KANDIRA
 
Cardiac tamponade
Cardiac tamponadeCardiac tamponade
Cardiac tamponade
ANILKUMAR BR
 
293. ischemic heart disease
293. ischemic heart disease293. ischemic heart disease
293. ischemic heart disease
Abdulhakeem Azzam
 
Myocardial Infarction
Myocardial InfarctionMyocardial Infarction
Myocardial Infarction
Mandeep Singh
 
An Overview of Unstable angina
An Overview of Unstable anginaAn Overview of Unstable angina
An Overview of Unstable angina
Brajesh Lahri
 
Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)
Abdullah Ansari
 
Myocardial infarction with case
Myocardial infarction with caseMyocardial infarction with case
Myocardial infarction with case
RABYYA KAUSAR
 
Cardiogenic shock
Cardiogenic shock Cardiogenic shock
Cardiogenic shock
ANILKUMAR BR
 
ISCHEMIC HEART DISEASE
ISCHEMIC HEART DISEASEISCHEMIC HEART DISEASE
ISCHEMIC HEART DISEASE
Ankita Sain
 
Ischemic heart diseases..
Ischemic heart diseases..Ischemic heart diseases..
Ischemic heart diseases..
Harshad Deshpande
 
Acute coronary syndrome ppt
Acute coronary syndrome pptAcute coronary syndrome ppt
Acute coronary syndrome ppt
Dalia Zaafar
 
Cardiac dyrrythmias
Cardiac dyrrythmiasCardiac dyrrythmias
Cardiac dyrrythmias
MR. JAGDISH SAMBAD
 
Aneurysm
AneurysmAneurysm
Management of Ischemic heart diseases
Management of Ischemic heart diseasesManagement of Ischemic heart diseases
Management of Ischemic heart diseases
Sameh Abdel-ghany
 
Atrial fibrillation
Atrial fibrillation Atrial fibrillation
Atrial fibrillation
Debojyoti Sarkar
 
Cardiac arrest
Cardiac arrest Cardiac arrest
Cardiac arrest
Nimra Iqbal
 
shock
shock shock
shock
Dr Kumar
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
Shinjan Patra
 

What's hot (20)

Acute Coronary Syndrome
Acute Coronary SyndromeAcute Coronary Syndrome
Acute Coronary Syndrome
 
Myocardialinfarction
Myocardialinfarction Myocardialinfarction
Myocardialinfarction
 
ACUTE CORONARY SYNDROME
ACUTE CORONARY SYNDROMEACUTE CORONARY SYNDROME
ACUTE CORONARY SYNDROME
 
Cardiac tamponade
Cardiac tamponadeCardiac tamponade
Cardiac tamponade
 
293. ischemic heart disease
293. ischemic heart disease293. ischemic heart disease
293. ischemic heart disease
 
Myocardial Infarction
Myocardial InfarctionMyocardial Infarction
Myocardial Infarction
 
An Overview of Unstable angina
An Overview of Unstable anginaAn Overview of Unstable angina
An Overview of Unstable angina
 
Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)
 
Myocardial infarction with case
Myocardial infarction with caseMyocardial infarction with case
Myocardial infarction with case
 
Cardiogenic shock
Cardiogenic shock Cardiogenic shock
Cardiogenic shock
 
ISCHEMIC HEART DISEASE
ISCHEMIC HEART DISEASEISCHEMIC HEART DISEASE
ISCHEMIC HEART DISEASE
 
Ischemic heart diseases..
Ischemic heart diseases..Ischemic heart diseases..
Ischemic heart diseases..
 
Acute coronary syndrome ppt
Acute coronary syndrome pptAcute coronary syndrome ppt
Acute coronary syndrome ppt
 
Cardiac dyrrythmias
Cardiac dyrrythmiasCardiac dyrrythmias
Cardiac dyrrythmias
 
Aneurysm
AneurysmAneurysm
Aneurysm
 
Management of Ischemic heart diseases
Management of Ischemic heart diseasesManagement of Ischemic heart diseases
Management of Ischemic heart diseases
 
Atrial fibrillation
Atrial fibrillation Atrial fibrillation
Atrial fibrillation
 
Cardiac arrest
Cardiac arrest Cardiac arrest
Cardiac arrest
 
shock
shock shock
shock
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 

Similar to Acute myocardial infarction

Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...
Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...
Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...
DrManojGodara
 
Myocardial Infarction
Myocardial Infarction Myocardial Infarction
Myocardial Infarction
Toukir Ahamed
 
Pathology of heart
Pathology of heartPathology of heart
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
Ivan Luyimbazi
 
ACUTE CORONARY SYNDROME.pptx
ACUTE CORONARY SYNDROME.pptxACUTE CORONARY SYNDROME.pptx
ACUTE CORONARY SYNDROME.pptx
UMAMAMOHAMMADARIF
 
Cardiac arrest an overview of defibrillation vs cardioversion
Cardiac arrest an overview of defibrillation vs cardioversionCardiac arrest an overview of defibrillation vs cardioversion
Cardiac arrest an overview of defibrillation vs cardioversion
Umair Sheikh
 
ACS.ppt
ACS.pptACS.ppt
ACS.ppt
hufane1
 
Acute coronary syndromes
Acute coronary syndromesAcute coronary syndromes
Acute coronary syndromes
meducationdotnet
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
Sean M. Fox
 
9572195.ppt
9572195.ppt9572195.ppt
9572195.ppt
anesthesia2023
 
acute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdfacute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdf
jiregnaetichadako
 
Dvt&pe
Dvt&peDvt&pe
Acute MI . family Medicine . 2022.pptx
Acute MI . family Medicine . 2022.pptxAcute MI . family Medicine . 2022.pptx
Acute MI . family Medicine . 2022.pptx
RasheedIbdah
 
Tachyarrythmias.pdf
Tachyarrythmias.pdfTachyarrythmias.pdf
Tachyarrythmias.pdf
Ghaiidaakhh1
 
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseAnaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Zareer Tafadar
 
Afshan ali myocardial infarction
Afshan ali myocardial infarctionAfshan ali myocardial infarction
Afshan ali myocardial infarction
Aamir Sharif
 
ACS (STEMI).pptx
ACS (STEMI).pptxACS (STEMI).pptx
ACS (STEMI).pptx
ssuserb91f2d
 
ECG, rapid review of essential topics
ECG, rapid review of essential topicsECG, rapid review of essential topics
ECG, rapid review of essential topics
Mahdi Najafi
 
Ami
AmiAmi
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
salman habeeb
 

Similar to Acute myocardial infarction (20)

Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...
Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...
Acute coronary syndrome. Diagnosis, treatment and prophylaxis of myocardial i...
 
Myocardial Infarction
Myocardial Infarction Myocardial Infarction
Myocardial Infarction
 
Pathology of heart
Pathology of heartPathology of heart
Pathology of heart
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
ACUTE CORONARY SYNDROME.pptx
ACUTE CORONARY SYNDROME.pptxACUTE CORONARY SYNDROME.pptx
ACUTE CORONARY SYNDROME.pptx
 
Cardiac arrest an overview of defibrillation vs cardioversion
Cardiac arrest an overview of defibrillation vs cardioversionCardiac arrest an overview of defibrillation vs cardioversion
Cardiac arrest an overview of defibrillation vs cardioversion
 
ACS.ppt
ACS.pptACS.ppt
ACS.ppt
 
Acute coronary syndromes
Acute coronary syndromesAcute coronary syndromes
Acute coronary syndromes
 
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced CardiomyopathyEMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
EMGuideWire's Radiology Reading Room: Stress-Induced Cardiomyopathy
 
9572195.ppt
9572195.ppt9572195.ppt
9572195.ppt
 
acute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdfacute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdf
 
Dvt&pe
Dvt&peDvt&pe
Dvt&pe
 
Acute MI . family Medicine . 2022.pptx
Acute MI . family Medicine . 2022.pptxAcute MI . family Medicine . 2022.pptx
Acute MI . family Medicine . 2022.pptx
 
Tachyarrythmias.pdf
Tachyarrythmias.pdfTachyarrythmias.pdf
Tachyarrythmias.pdf
 
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseAnaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart Disease
 
Afshan ali myocardial infarction
Afshan ali myocardial infarctionAfshan ali myocardial infarction
Afshan ali myocardial infarction
 
ACS (STEMI).pptx
ACS (STEMI).pptxACS (STEMI).pptx
ACS (STEMI).pptx
 
ECG, rapid review of essential topics
ECG, rapid review of essential topicsECG, rapid review of essential topics
ECG, rapid review of essential topics
 
Ami
AmiAmi
Ami
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 

More from Dr. Muhammad Saifullah

Treatment of myocarditis
Treatment of myocarditisTreatment of myocarditis
Treatment of myocarditis
Dr. Muhammad Saifullah
 
Thalamus, its functions and thalamic syndrome
Thalamus, its functions and thalamic syndromeThalamus, its functions and thalamic syndrome
Thalamus, its functions and thalamic syndrome
Dr. Muhammad Saifullah
 
Regional anesthesia
Regional anesthesiaRegional anesthesia
Regional anesthesia
Dr. Muhammad Saifullah
 
Preparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistanPreparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistan
Dr. Muhammad Saifullah
 
Interior ballistics / Internal ballistics
Interior ballistics / Internal ballisticsInterior ballistics / Internal ballistics
Interior ballistics / Internal ballistics
Dr. Muhammad Saifullah
 
Insulin and its Uses
Insulin and its UsesInsulin and its Uses
Insulin and its Uses
Dr. Muhammad Saifullah
 
High intensity Focused Ultrasound / HIFU
High intensity Focused Ultrasound / HIFUHigh intensity Focused Ultrasound / HIFU
High intensity Focused Ultrasound / HIFU
Dr. Muhammad Saifullah
 
Fluids & Electrolyte Management of the surgical patient
Fluids & Electrolyte Management of the surgical patientFluids & Electrolyte Management of the surgical patient
Fluids & Electrolyte Management of the surgical patient
Dr. Muhammad Saifullah
 
Duties of a house surgeon / Foundation Doctor
Duties of a house surgeon / Foundation DoctorDuties of a house surgeon / Foundation Doctor
Duties of a house surgeon / Foundation Doctor
Dr. Muhammad Saifullah
 
Balanitis Xerotica Obliterans / BXO / Penile Lichen Sclerosis
Balanitis Xerotica Obliterans / BXO / Penile Lichen SclerosisBalanitis Xerotica Obliterans / BXO / Penile Lichen Sclerosis
Balanitis Xerotica Obliterans / BXO / Penile Lichen Sclerosis
Dr. Muhammad Saifullah
 
Bladder cancer management
Bladder cancer managementBladder cancer management
Bladder cancer management
Dr. Muhammad Saifullah
 
Bladder cancer Epidemiology and Etiology
Bladder cancer Epidemiology and Etiology Bladder cancer Epidemiology and Etiology
Bladder cancer Epidemiology and Etiology
Dr. Muhammad Saifullah
 
Bladder Cancer Diagnostic Modalities
Bladder Cancer Diagnostic ModalitiesBladder Cancer Diagnostic Modalities
Bladder Cancer Diagnostic Modalities
Dr. Muhammad Saifullah
 
Bladder mass clinical features & staging
Bladder mass clinical features & stagingBladder mass clinical features & staging
Bladder mass clinical features & staging
Dr. Muhammad Saifullah
 
Arterio venous fistulae using grafts
Arterio venous fistulae using graftsArterio venous fistulae using grafts
Arterio venous fistulae using grafts
Dr. Muhammad Saifullah
 
Peyronie`s disease / Acquired Penile deformity
Peyronie`s disease / Acquired Penile deformityPeyronie`s disease / Acquired Penile deformity
Peyronie`s disease / Acquired Penile deformity
Dr. Muhammad Saifullah
 
Bladder pain syndrome / Interstitial Cystitis
Bladder pain syndrome / Interstitial CystitisBladder pain syndrome / Interstitial Cystitis
Bladder pain syndrome / Interstitial Cystitis
Dr. Muhammad Saifullah
 
Wilms tumour / Nephroblastoma
Wilms tumour / Nephroblastoma Wilms tumour / Nephroblastoma
Wilms tumour / Nephroblastoma
Dr. Muhammad Saifullah
 
Renal cyst / Classification of Renal Cyst
Renal cyst / Classification of Renal CystRenal cyst / Classification of Renal Cyst
Renal cyst / Classification of Renal Cyst
Dr. Muhammad Saifullah
 
Arterio venous fistulae using grafts
Arterio venous fistulae using graftsArterio venous fistulae using grafts
Arterio venous fistulae using grafts
Dr. Muhammad Saifullah
 

More from Dr. Muhammad Saifullah (20)

Treatment of myocarditis
Treatment of myocarditisTreatment of myocarditis
Treatment of myocarditis
 
Thalamus, its functions and thalamic syndrome
Thalamus, its functions and thalamic syndromeThalamus, its functions and thalamic syndrome
Thalamus, its functions and thalamic syndrome
 
Regional anesthesia
Regional anesthesiaRegional anesthesia
Regional anesthesia
 
Preparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistanPreparation of case for living related renal transplant in pakistan
Preparation of case for living related renal transplant in pakistan
 
Interior ballistics / Internal ballistics
Interior ballistics / Internal ballisticsInterior ballistics / Internal ballistics
Interior ballistics / Internal ballistics
 
Insulin and its Uses
Insulin and its UsesInsulin and its Uses
Insulin and its Uses
 
High intensity Focused Ultrasound / HIFU
High intensity Focused Ultrasound / HIFUHigh intensity Focused Ultrasound / HIFU
High intensity Focused Ultrasound / HIFU
 
Fluids & Electrolyte Management of the surgical patient
Fluids & Electrolyte Management of the surgical patientFluids & Electrolyte Management of the surgical patient
Fluids & Electrolyte Management of the surgical patient
 
Duties of a house surgeon / Foundation Doctor
Duties of a house surgeon / Foundation DoctorDuties of a house surgeon / Foundation Doctor
Duties of a house surgeon / Foundation Doctor
 
Balanitis Xerotica Obliterans / BXO / Penile Lichen Sclerosis
Balanitis Xerotica Obliterans / BXO / Penile Lichen SclerosisBalanitis Xerotica Obliterans / BXO / Penile Lichen Sclerosis
Balanitis Xerotica Obliterans / BXO / Penile Lichen Sclerosis
 
Bladder cancer management
Bladder cancer managementBladder cancer management
Bladder cancer management
 
Bladder cancer Epidemiology and Etiology
Bladder cancer Epidemiology and Etiology Bladder cancer Epidemiology and Etiology
Bladder cancer Epidemiology and Etiology
 
Bladder Cancer Diagnostic Modalities
Bladder Cancer Diagnostic ModalitiesBladder Cancer Diagnostic Modalities
Bladder Cancer Diagnostic Modalities
 
Bladder mass clinical features & staging
Bladder mass clinical features & stagingBladder mass clinical features & staging
Bladder mass clinical features & staging
 
Arterio venous fistulae using grafts
Arterio venous fistulae using graftsArterio venous fistulae using grafts
Arterio venous fistulae using grafts
 
Peyronie`s disease / Acquired Penile deformity
Peyronie`s disease / Acquired Penile deformityPeyronie`s disease / Acquired Penile deformity
Peyronie`s disease / Acquired Penile deformity
 
Bladder pain syndrome / Interstitial Cystitis
Bladder pain syndrome / Interstitial CystitisBladder pain syndrome / Interstitial Cystitis
Bladder pain syndrome / Interstitial Cystitis
 
Wilms tumour / Nephroblastoma
Wilms tumour / Nephroblastoma Wilms tumour / Nephroblastoma
Wilms tumour / Nephroblastoma
 
Renal cyst / Classification of Renal Cyst
Renal cyst / Classification of Renal CystRenal cyst / Classification of Renal Cyst
Renal cyst / Classification of Renal Cyst
 
Arterio venous fistulae using grafts
Arterio venous fistulae using graftsArterio venous fistulae using grafts
Arterio venous fistulae using grafts
 

Recently uploaded

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 

Recently uploaded (20)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
 

Acute myocardial infarction

  • 1.
  • 2.
  • 4. Distribution of coronary blood supply Right Coronary Artery Left Coronary Artery Right atrium Right ventricle SA node (85%) AV node Inter-atrial septum Portion of left atrium Postero-inferior 1/3 of Inter- ventricular septum Portion of posterior part of left ventricle Left atrium Left ventricle Most of the Interventricular septum Atrio-ventricular bundle and its branches
  • 5. ACUTE MYOCARDIAL INFARCTION • Cardiac muscle necrosis secondary to protracted lack of coronary perfusion • Usual etiology: Thrombus at site of vascular injury
  • 6. OTHER ETIOLOGIES OF ACUTE MYOCARDIAL INFARCTION • Coronary embolus • Coronary spasm • Coronary anomoly • Primary in situ thrombosis • Vasculitis • Hypotension
  • 7. DETERMINANTS OF EXTENT OF DAMAGE • Territory supplied • Duration of occlusion • Existence of collaterals • Oxygen demand at time of occlusion • Vasospasm
  • 8. RISK FACTORS Risk factors for atherosclerosis are generally risk factors for myocardial infarction Diabetes (with or without insulin resistance) – the single most important risk factor for ischaemic heart disease (IHD) Tobacco smoking Hypercholesterolemia Low HDL
  • 9. High blood pressure Family history of ischaemic heart disease (IHD) Obesity Age: Men at age 45 & Women at age 55 Hyperhomocysteinemia (high homocysteine, a toxic blood amino acid that is elevated when intakes of vitamins B2, B6, B12 and folic acid are insufficient) Stress Alcohol Males are more at risk than females
  • 10. Presenting Symptoms of Acute MI • Pain- *typical-crushing substernal chest pain *atypical - jaw, neck, shoulder, back pain, indigestion *painless - “silent” • Dyspnea- systolic and/or diastolic dysfunction • Dizziness-hypotension, arrhythmia • Nausea, vomiting • Elderly patients: Failure to thrive • Anxiety, restlessness
  • 12. Presenting Signs in Acute MI • Appearance: Pallor, diaphoretic, anxious • Vital Signs: Normal or abnormal BP and P – Hypertension and tachycardia: SNS – Hypotension and tachycardia: • Cardiogenic shock • Myocardial rupture • Tachyarrhythmia – Hypotension and bradycardia • vagal stimulation • Bradyarhythmia
  • 13. Presenting Signs in Acute MI (Cont.) • Lungs: Rales - CHF • Heart: Displaced LV impulse –S3 –S4 –Murmur of mitral regurgitation –Murmur of ventricular septal rupture –Pericardial rub
  • 14. DIAGNOSIS The diagnosis of myocardial infarction can be made after assessing Patient's complaints and physical status ECG changes Coronary angiogram Levels of cardiac markers
  • 15.
  • 16. ORDER OF ECG CHANGES IN AMI  Earliest: Increased R and T wave amplitudes; giant R wave and Hyperacute T waves  Progressive ST elevation  Q waves appear  Loss of R waves  “T wave” inversion (because of change in ventricular repolarisation) and it persists
  • 17.
  • 19. Electrocardiographic Differential Diagnosis of the Hyperacute T Wave A: AMI B: AMI C: Hyperkalemia D: Benign Early Repolarization E: Acute Pericarditis F: LBBB G: LVH
  • 21. INFARCTION DISTRIBUTION TERRITORY ECG LEADS ARTERY Anterior V2-V6 LAD Inferior II,III, aVF RCA Lateral I, aVL, V5-V6 Circumflex Posterior Tall R in V1-V2 Variable
  • 23.
  • 24. ANTEROLATERAL AMI STE in V2-V4 Anterior STE in I, aVL, V5-V6 Lateral
  • 25.
  • 26. LATERAL AMI STE in I, aVL *Note the ST depression in II, III, aVF consistent with reciprocal changes, as well as in V2-V3 which may represent a posterior MI
  • 27.
  • 28. INFERIOR AMI STE in II, III, aVF *Note the ST depression in I, aVL consistent with reciprocal change, as well as in V1-V4 representing a posterior MI
  • 29.
  • 30. POSTERIOR WALL AMI ST Segment Depression in V1-V3 and posterior thoracic leads with STE
  • 31.
  • 32. PLASMA MARKERS CK-MB Increases at 4-6 hours Peaks at 12 hours Normalizes in 48-72 hours TROPONIN T & I Increases at 4-6 hours Remains elevated for 2 weeks
  • 33. Creatine Phosphokinase (CK) • Rises within 4-8 hours, rapidly cleared by 24-24 hours • Other Sources: – Skeletal – Hypothyroidism – Renal failure – Stroke • Isoenzymes – MM skeletal muscle – BB brain – MB cardiac • CKMB≥ 4% suggests acute myocardial infarction+++
  • 34. Cardiac Specific Troponins (cTnT, cTnI) • Rise within 4-8 hours, remain elevated 7-14 days (T>I) • 30% of patients with UAP show ↑ levels cTnT or I, indicating increased risk of adverse outcome
  • 35.
  • 36. OTHER TESTS BLOOD leukocytosis, ESR and CRP is elevated Chest X-ray Pulmonary edema Echocardiography Mural thrombi Cardiac rupture VSD MR Pericardial effusion
  • 37. DIAGNOSIS OF MYOCARDIAL INFARCTION (American college of cardiology and the Europeon society of cardiology) Elevated Troponins or CK-MB above 99th centile with one of the following Ischemic symptoms Development of Q-waves on ECG Ischemic ECG changes (ST elevation/depression) Coronary artery intervention
  • 38. A. IMMEDIATE MANAGEMENT B. MAINTAINING VESSEL PATENCY C. PREVENTION OF FURTHER COMPLICATIONS D. LATE MANAGEMENT Defibrillation services Resuscitation Reperfusion Detection and Management of acute complications Drugs Adjunctive therapy Arrythmias Ischemia Acute circulatory failure Pericarditis Mechanical complications Embolism Impaired ventricular function Ventricular aneurysm Risk stratification and management Life style modification Drug therapy in Secondary Prevention Mobilization and Rehabilitation
  • 39. A. IMMEDIATE MANAGEMENT DEFIBRILLATOR IMMEDIATE MEASURES 1.High flow oxygen 2.IV access 3.ECG monitoring 4.IV analgesics (Morphine Sulphate 5-10 mg) 5.Anti-emetics (Metoclopramide 100mg) 6.Anti-platelets (Aspirin 300mg)
  • 40. REPERFUSION  Primary PCI is the treatment of choice  Thrombolysis (Greatest benefits if in 2 hours) Streptokinase 1.5 Million Units in 100ml of N/S over 1 hour Alteplase 15mg bolus then 0.75mg/kg in 30 mins (50mg) followed by 0.5mg/kg in 60 min (35mg) Major hazard is Cerebral Haemorrhage DETECTION AND MANAGEMENT OF ACUTE COMPLICATIONS  Arrythmias  Ischemia  Heart failure
  • 41. Major Contraindications To the Use of Thrombolytic Therapy • Any previous history of hemorrhagic stroke • History of stroke, dementia, or central nervous system damage within 1 year • Head trauma or brain surgery within 6 months • Known intracranial neoplasm • Suspected aortic dissection • Internal bleeding within 6 weeks • Active bleeding or known bleeding disorder • Major surgery, trauma, or bleeding within 6 weeks • Traumatic cardiopulmonary resuscitation within 3 weeks
  • 42. Relative Contraindications To the Use of Thrombolytic Therapy • Oral anticoagulant therapy • Acute pancreatitis • Pregnancy or within 1 week postpartum • Active peptic ulceration • Transient ischemic attack within 6 months • Dementia • Infective endocarditis • Active cavitating pulmonary tuberculosis • Advanced liver disease • Intracardiac thrombi • Uncontrolled hypertension (systolic blood Pressure >180 mm Hg, diastolic blood pressure > 110 mm Hg • Puncture of noncompressible blood vessel within 2 weeks • Previous streptokinase therapy
  • 43. Risks of Coronary Angiography: (all are rare) • Stroke • Myocardial infarction • Arrhythmia • Renal failure • Allergic reaction to contrast agent
  • 44. B. MAINTAINING VESSEL PATENCY • Anti-platelets Aspirin 75-300mg daily and/or Clopidogrel 75mg daily • Anti-coagulants S/C Heparin 12,500 units twice daily IV Heparin (within 48-72 hrs of thrombolysis) Warfarin in Persistant A.Fibrillation & Extensive anterior infarction • Adjunctive therapy B-Blockers Atenolol 5-10mg to dec. pain and arrythmias but should be avoided in HF, AV Block and severe bradycardia Nitrates S/L GTN 300-500 mcg in threatened MI and IV nitrates (Nitroglycerin 0.6-1.2mg/hour or Isosorbide dinitrate are useful in treating LVF and Ischemic pain relief.
  • 45. C. FURTHER COMPLICATIONS AND THEIR PREVENTION 1. ARRYTHMIAS (VF, VT, AF, AT, Heart blocks and Ventricular ectopics) Can be avoided by Pain relief, Rest and Correction of hypokalemia • Vent. Fib….5-10% cases…..prompt defibrillation • Atrial Fib….transient and rarely requires treatment ….DC cardioversion, Digoxin or B-Blocker are TOCs…..Patient can go into LVF so give Anticoagulants • AV block….Atropine 0.6mg IV + Temporary pacemaker
  • 46. 2. ISCHEMIA 50% cases known as post-infarct Angina Managed as Unstable Angina • IV nitrates (0.6-1.2mg/hour) • IV heparin (1000 units/hour)…dose adjusted to PT • LMWH • GP IIb/IIIa receptor antagonists…..selected cases 3. ACUTE CIRCULATORY FAILURE in extensive myocardial damage 4. PERICARDITIS (on 2nd and 3rd day) Opiod based analgesics Also called Post-Infarction syndrome/Dressler’s syndrome…..fever, pericarditis and pleurisy (due to auto-immunity)….may require High dose Aspirin, other NSAIDS and Cortico-steriods.
  • 47. 5. MECHANICAL COMPLICATIONS Papillary muscle damage…..acute onset pulmonary edema due to severe MR (PSM + S3)…..diagnosed by doppler’s echocardiography and treated by emergency mitral valve replacement Ruptured IV septum…..Left to right shunt (PSM radiating to right sternal border difficult to distinguish from MR) …..diagnosed on doppler’s echocardiography …..fatal condition Ventricular rupture…..cardiac tamponade…..fatal 6. EMBOLISM risk is decreased by prophylactic ani- coagulants and early mobilization
  • 48. 7.IMPAIRED VENTRICULAR FUNCTION Due to infarct expansion…..lead to progressive dilataion of the infarcted area and hypertrophy of the rest of the portion 8. VENTRICULAR ANEURYSM 10% cases Leads to HF, Ventricular arrythmias, Mural thrombus and systemic embolism Echocardiography is diagnostic Surgical removal improves the chances of survival
  • 49. D. LATE MANAGEMENT 1. RISK STRATIFICATION LV FUNCTION ISCHEMIA ARRYTHMIAS •Physical findings … tachycardia, S3, Crackles at lung bases and elevated venous pressure •ECG changes •Size of heart and Pulmonary edema on CXR •Post-infarct angina … treat like unstable angina •CABG •Implantable cardiac defibrillators
  • 50. 2. LIFE STYLE MODIFICATION  Quit smoking (5 year mortality twice if you don’t quit)  Regular exercise (20min/day for 3 days/week)  Diet control to decrease weight and lipid lowering
  • 51. 3. DRUG THERAPY (Secondary prevention) Statins…best results when level of LDL is greater than 3.2 mmol/L….Atovstatin 80mg OD Anti-platelets…Aspirin/Clopidogrel B-Blockers….but contra-indicated in Bradycardia, AV block, hypotension and Asthma ACE inhibitors….Enalapril 10mg BD, Ramipril 2.5-5mg BD Angiotensin receptor antagonists….valsartan 40-160mg OD, Candesartan 4-16mg OD Control of HTN and DM 4. MOBILIZATION AND REHABILITATION start working in 4-6 weeks
  • 52. CARDIAC REHABILITATION •Healthcare professionals, should actively promote cardiac rehabilitation. •Cardiac rehabilitation should be equally accessible and relevant to all patients after an acute MI.
  • 53. COMPONENTS OF CARDIAC REHABILITATION • The guideline recommends that cardiac rehabilitation should include: • education • exercise • stress management
  • 54. CARDIOLOGICAL ASSESSMENT All patients should be offered a cardiological assessment to consider whether coronary revascularisation is appropriate.
  • 55. ABCs of Treatment and Secondary Prevention of AMI • Aspirin-prophylactic Rx for recurrent ischemic events; give for at least 3 mo. after AMI, probably indefinitely • Beta blockers-prophylactic, for reduction of cardiac mortality; Rx for 2 yr-indefinitely • Converting enzyme inhibitors-all pts with LV dysfunction to reduce risk of progressive heart failure and death. • Diet and lipid lowering Rx-statins have been shown to reduce risk of subsequent MI, need for revascularization and mortality (4S, Care) • Exercise and rehabilitation-essential in restoration of confidence and improvement in quality of life
  • 56. PROGNOSIS • 1/4th of the patients suffering acute MI die in few min due to any arrythmia • Half of the MI deaths occur in 1st 24 hours • 40% of the rest die in 1st Month • Anterior infarcts are worse than Inferior infarcts • BBB and increased enzymes reflects that the damage is extensive • Increased mortality is associated with old age,depression and social isolation
  • 57. SURVIVAL CHANCES After surviving an acute attack…. • 80 % Survive the 1st year • 75 % Survive upto 5 years • 50% Survive upto 10 years • 25% survive upto 20 years

Editor's Notes

  1. NOTES FOR PRESENTERS The key recommendation on cardiac rehabilitation says that: ‘Cardiac rehabilitation should be equally accessible and relevant to all patients after an MI, particularly people from groups that are less likely to access this service. These include people from black and minority ethnic groups, older people, people from lower socioeconomic groups, women, people from rural communities and people with mental and physical health comorbidities.’ (page 6, NICE guideline) ‘Healthcare professionals, including senior medical staff involved in providing care for patients after an MI, should actively promote cardiac rehabilitation’ (page 12, NICE guideline)
  2. NOTES FOR PRESENTERS ‘A home based programme validated for patients who have had an MI that incorporates education, exercise and stress management components with follow-ups by a trained facilitator may be used to provide comprehensive cardiac rehabilitation’ (such as ‘The Edinburgh heart manual’; see www.cardiacrehabilitation.org.uk/heart_manual/heartmanual.htm) (page 12. NICE guideline) Education should include issues such as: when to return to work driver and vehicle licensing agency guidelines when it is safe to travel by air sexual activity how to use a perceived exertion scale to help monitor physiological demand advice on competitive sport when relevant advice to contact Civil Aviation Authority if the patient holds a pilot’s licence. The exercise component should be designed to meet the needs of older patients or patients with significant comorbidity.
  3. NOTES FOR PRESENTERS The key recommendation on cardiological assessment says that: ‘All patients should be offered a cardiological assessment to consider whether coronary revascularisation is appropriate. This should take into account comorbidity.’ (page 7, NICE guideline) The Guideline Development Group concluded that there was evidence of effectiveness of coronary revascularisation for secondary prevention in selected stable patients with non-acute coronary disease, and thus patients after MI who had not been considered for coronary revascularisation during the acute phase of management should be considered for further specialist cardiological assessment.